Sindhu Subramanian*
Assistant Professor, Department of Chemical Engineering and Materials Science, Amrita School of Engineering, Coimbatore, Amrita Vishwa Vidyapeetham, India
*Corresponding Author: Sindhu Subramanian, Assistant Professor, Department of Chemical Engineering and Materials Science, Amrita School of Engineering, Coimbatore, Amrita Vishwa Vidyapeetham, India.
Received: March 26, 2020; Published: May 20, 2020
Elevated blood pressure significantly increases the risks of non-communicable diseases such as cardiovascular, nervous and renal related problem. 1.13 billion people worldwide are estimated to have hypertension in which two-thirds were living in under-developing and developing countries. One of the global targets mentioned by WHO is to reduce the prevalence of hypertension by 25% before 2025. Various antihypertensive agents such as Calcium channel blockers, thiazide diuretics, angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) and ß-blockers are used to treat hypertension. Among these, Calcium channel blockers have shown best effect to reduce hypertension compared to the other recommended agents.
Citation: Sindhu Subramanian. “Nanoparticle based Drug Delivery Systems for the Controlled Release of Antihypertensive Drugs". Acta Scientific Pharmacology 1.6 (2020): 01.
Copyright: © 2020 Sindhu Subramanian. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
